| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2020 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | SVP And General Counsel | Sell | 1,552 | $15.79 | $24,501.42 | -1.3% | |
| Feb 27, 2020 | LNTH Lantheus Holdings, Inc. | McHugh Julie53 | Director | Sell | 1,756 | $15.86 | $27,844.89 | -10.0% | |
| Feb 27, 2020 | LNTH Lantheus Holdings, Inc. | Bolla John J. | Chief Operations Officer | Sell | 1,251 | $15.79 | $19,749.54 | -3.4% | |
| Feb 27, 2020 | LNTH Lantheus Holdings, Inc. | Robertson A Frederick | Director | Sell | 2,660 | $15.86 | $42,192.92 | -6.2% | |
| Feb 27, 2020 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 31,615 | $16.27 | $514,318.67 | -2.9% | |
| Feb 27, 2020 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 23,456 | $57.97 | $1,359,849.19 | -0.8% | |
| Feb 26, 2020 | ANIK Anika Therapeutics, Inc. | Land Raymond J | Director | Sell | 2,700 | $42.68 | $115,236.00 | -16.8% | |
| Feb 25, 2020 | ZTS Zoetis Inc. | Peck Kristin C66 | Chief Executive Officer | Sell | 11,925 | $138.10 | $1,646,787.25 | -12.5% | |
| Feb 25, 2020 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | SVP And General Counsel | Sell | 6,563 | $16.85 | $110,566.86 | -5.3% | |
| Feb 24, 2020 | ALKS Alkermes Plc. | Wysenski Nancy | Director | Buy | 6,940 | $19.65 | $136,371.00 | +161.3% | |
| Feb 24, 2020 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 9,898 | $16.06 | $158,969.80 | -1.7% | |
| Feb 24, 2020 | IRWD Ironwood Pharmaceuticals Inc | Mallon Mark | Chief Executive Officer | Sell | 7,984 | $11.63 | $92,853.54 | -1.3% | |
| Feb 21, 2020 | IRWD Ironwood Pharmaceuticals Inc | Consylman Gina | SVP, CFO &Treasurer | Sell | 12,501 | $11.63 | $145,386.63 | -1.5% | |
| Feb 21, 2020 | ZTS Zoetis Inc. | Alaix Juan Ramon | Director | Sell | 120,353 | $142.32 | $17,128,638.96 | -55.6% | |
| Feb 21, 2020 | JNJ Johnson & Johnson | Mongon Thibaut | Exec VP, Ww Chair, Consumer | Sell | 39,224 | $147.96 | $5,803,583.04 | -52.3% | |
| Feb 21, 2020 | EBS Emergent Biosolutions Inc. | Hauer Jerome M | Director | Sell | 6,572 | $70.00 | $460,040.00 | -35.9% | |
| Feb 21, 2020 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 5,152 | $65.00 | $334,880.00 | -23.9% | |
| Feb 21, 2020 | IRWD Ironwood Pharmaceuticals Inc | Gilbert Halley E | Chief Admin Officer &SVP | Sell | 15,328 | $11.63 | $178,264.64 | -1.4% | |
| Feb 21, 2020 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | President | Sell | 4,177 | $11.63 | $48,578.51 | -0.9% | |
| Feb 21, 2020 | IRWD Ironwood Pharmaceuticals Inc | MacDonald Kelly | Chief Accounting Officer | Sell | 3,900 | $11.63 | $45,357.00 | -0.8% | |
| Feb 21, 2020 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 23,318 | $64.90 | $1,513,338.20 | -0.8% | |
| Feb 20, 2020 | LLY Eli Lilly & Co | Bald Eagle Acquisition Corp | 10% Owner | Buy | 40,926,025 | $18.75 | $767,362,968.75 | -100.0% | |
| Feb 20, 2020 | ZTS Zoetis Inc. | Alaix Juan Ramon | Director | Sell | 83,771 | $143.93 | $12,056,894.63 | -22.5% | |
| Feb 20, 2020 | KNSA Kiniksa Pharmaceuticals International, Plc | Paolini John F.51 | SVP &Chief Medical Officer | Sell | 32,280 | $18.48 | $596,487.08 | -36.9% | |
| Feb 19, 2020 | ZTS Zoetis Inc. | Chen Heidi C.47 | Executive Vice President | Sell | 3,289 | $143.41 | $471,675.49 | -16.8% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.